HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 828 | 1011 | 81.9% | |
| HF 4 | 2012 | 887 | 1078 | 82.3% | |
| HF 4 | 2013 | 895 | 1040 | 86.1% | |
| HF004 | 2014 | 543 | 574 | 94.6% | |
| HF004 | 2015 | 617 | 667 | 92.5% | |
| HF004 | 2016 | 759 | 810 | 93.7% | |
| HF004 | 2017 | 902 | 952 | 94.7% | |
| HF004 | 2018 | 1085 | 1150 | 94.3% | |
| HF004 | 2019 | 1243 | 1338 | 92.9% | |
| HF004 | 2020 | 1210 | 1314 | 92.1% | |
| HF006 | 2021 | 1424 | 1543 | 92.3% | |
| HF006 | 2022 | 1543 | 1609 | 95.9% | |
| HF006 | 2023 | 1728 | 1789 | 96.6% |
